CHARLESTON, S.C., May 31, 2012 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCQB:RMCP) announced today that it has taken delivery of the first one million units of the 3ml RevVac™ auto-retractable vacuum safety syringe from its manufacturing partner, Yeso-med, in Wuxi, China. The one million units will be shipped via ocean freight to the Port of Charleston, South Carolina. Yeso-med affirmed the units passed all applicable quality tests as defined in the ISO 7886-1 and 7886-3 specifications.
Ron Wheet, Chief Executive Officer and Chairman of Revolutions Medical, stated, "This represents another significant milestone for the Company. To ensure that our first syringe order from the new production facility met all of our internal quality controls and procedures, we took extra time and tested a larger sample lot prior to taking delivery. The Company now has the confidence to produce millions of the RevVac™ safety syringe per month meeting the highest quality standards for our customers."
About Revolutions Medical Corporation
Revolutions Medical is a safety medical device and software application company. Its products include the RevVac™ Safety Syringe (FDA cleared), safety blood drawing device, the RevColor™, RevDisplay™, and Rev3D™ software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS).
For additional information, please visit Revolutions Medical corporate website: http://www.revolutionsmedical.com/
To be added to the Revolutions Medical investor email list, please email: investment@revolutionsmedical.com with RMCP in the subject line.
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.